Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
Date:10/23/2008

ngs derived from Anadys' completed strategic restructuring.

Operating expenses were $9.7 million for the third quarter of 2008, compared to $10.0 million for the third quarter of 2007. Included as a component of Anadys' operating expenses were non-cash, share-based expenses of $0.7 million and $1.4 million for the third quarter of 2008 and 2007, respectively.

The net loss was $9.3 million for the third quarter of 2008, compared to net income of $12.3 million for the third quarter of 2007. Basic and diluted net loss per common share was $0.32 in the third quarter of 2008, compared to net income per common share of $0.43 in the third quarter of 2007. Non-cash share-based expense resulted in a $0.03 increase in basic and diluted net loss per share for the third quarter of 2008 compared to a $0.05 decrease in basic and diluted net income per share for the third quarter 2007.

During the nine months ended September 30, 2008 the Company had no revenue, compared to $23.9 million for the same period in 2007. The revenue recognized in the first nine months of 2007 was primarily derived from the amortization of an upfront payment and a milestone payment under a prior collaboration and the recognition of the previously deferred revenue upon termination of the collaboration. Operating expenses during the nine months ended September 30, 2008 were $25.2 million compared to $28.1 million for the nine months ended September 30, 2007. The decrease in operating expenses was a result of cost savings derived from Anadys' completed restructuring partially offset by increases in development costs for ANA598 and ANA773. For the nine months ended September 30, 2008, Anadys reported a net loss of $23.9 million, compared to $1.4 million for the same period last year. Basic and diluted net loss per common share was $0.83 for the nine months ended September 30, 2008, compared to $0.05 for the same period in 2007.

Recent Development Program Highlights

-- Phase
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
2. Anadys Pharmaceuticals to Report Third Quarter 2007 Financial Results
3. Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
6. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
7. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
8. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
9. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
10. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
11. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... The report on the Global Smart ... concerned market for revenue forecasts and market trends. It ... 51.9% from 2013 to 2018. At the projected rate, ... $1,415.6 million by 2018. , Browse through the Global ... information about the market segmentation and in-depth analysis supported ...
(Date:11/26/2014)... In keeping with the holiday spirit, ... last-minute Thanksgiving savings. The company is offering up a ... lines this holiday weekend as well as a photo ... Cyber Monday are right around the corner, and DNA ... customers and those looking to explore their ancestry, health, ...
(Date:11/26/2014)... , Nov. 26, 2014 The ... from a survey of European physicians at the ... Innovation and Biological Therapies" at the Spanish Ministry ... hosted by EuropaBio and the Spanish Bioindustry Association ... Health, physicians from Spanish oncology and rheumatology societies, ...
(Date:11/26/2014)... NC (PRWEB) November 26, 2014 PMG ... Advisory Board. PMG Research is a network of sites that ... access to over 2 million patient lives through its partnerships ... is comprised of 11 hub site locations in the Southeastern ... The first term of the board will be ...
Breaking Biology Technology:Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 2Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 3Global Smart Sensor Market in Building Automation is expected to reach a value of $1,415.6 million by 2018 - Report by MicroMarket Monitor 4DNA Spectrum Offers Last Minute Thanksgiving Coupons 2DNA Spectrum Offers Last Minute Thanksgiving Coupons 3ASBM Presents European Physicians Survey at Spanish Ministry of Health 2PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3
... develop a new drug that will regenerate a critical ... person is exposed to deadly chemical warfare agents. ... State University (OSU), is leveraging Ohio Supercomputer Center (OSC) ... lethal chemicals called organophosphorus (OP) nerve agents. ...
... disease. But can they work better, and safer? ... of administering therapeutics in a way that boosts their effectiveness ... potential damage to healthy tissue. The development ... and release them directly into cells holds great potential in ...
... way to wake up the immune system to fight ... nanoscale container called a vault directly into lung cancer ... growth. The vaults, barrel-shaped nanoscale capsules found in ... slowly release a protein, the chemokine CCL21, into the ...
Cached Biology Technology:OSU chemist developing solution to nerve agent exposure 2Scientists engineer nanoscale vaults to encapsulate 'nanodisks' for drug delivery 2Scientists engineer nanoscale vaults to encapsulate 'nanodisks' for drug delivery 3UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs 2UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs 3UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs 4
(Date:11/4/2014)... Medicine announced today that it is a Grand ... Bill & Melinda Gates Foundation. Laura Goetzl, ... Sciences; and Vice Chair of Research and Academic ... pursue an innovative global health and development research ... Neurodevelopment.", Grand Challenges Explorations (GCE) funds individuals worldwide ...
(Date:11/4/2014)... Nov. 4, 2014   Neurotechnology , a ... that the latest version of its fingerprint matching ... Ongoing MINEX evaluation organized by NIST. The ... using the INCITS 378 fingerprint standard template format. ... public tenders in the United States ...
(Date:11/2/2014)... Physics World , James Dacey explores the ways ... to take their innovations from the lab into the ... facing all start-up companies as they move from prototype ... two main factors: physics-based inventions are usually far from ... to be a lot more complicated than had been ...
Breaking Biology News(10 mins):Temple University School of Medicine receives Grand Challenges Explorations grant 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3The 'valley of death' facing physics start-ups 2
... Geology postings include understanding the "Mystery Interval" ... topographic change and recovery after the 2011 Tohoku-oki tsunami; ... an adaptive response during the Paleozoic; discovering that powerfully ... of a topographic barrier; and demonstrating for the first ...
... Entomological Society of America (ESA), has just announced that ... of Entomology, September 25-30, 2016 in Orlando, Florida. ... the largest gathering of scientists and experts in the ... of over 6,000 delegates. The Congress will be co-located ...
... , HOUSTON, Aug. 23, 2012 Scientists at the University ... key ingredient in the fight against Parkinson,s disease. ... is a degenerative disorder of the central nervous system marked ... causing a lack of dopamine. These dopamine-producing neurons are in ...
Cached Biology News:Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 2Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 3Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 4Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 5Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 6Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 7Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 8Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 9Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 10Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 11Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 12Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 13Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 14Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 15Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 16Geology's 'Mystery Interval,' the 'Great Deepening,' and the largest kill-off in Earth history 172016 International Congress of Entomology to be held in Orlando, Florida 22016 International Congress of Entomology to be held in Orlando, Florida 32016 International Congress of Entomology to be held in Orlando, Florida 4Therapeutic avenues for Parkinson's investigated at UH 2
Human PDGF, CF...
... The mycobacteria in ... cells to the injection site which enhances ... Freund's Adjuvant is used for the initial ... the subsequent boosts. Antigens (preferably in saline) ...
2,4-Dinitrophenyl hapten is conjugated to Keyhole Limpet (KLH) protein through lysine....
IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml...
Biology Products: